Chargers.com (Free subscription) | 08/21/2008
Each time a Charger scores a touchdown this season, theyll not only be helping their team but also the families affected by Huntingtons Disease.
Red Orbit (Free subscription) | 05/06/2008
Genetics researchers are reporting some exciting progress in the search for a cure for genetic brain-wasting diseases like huntingtons disease. The painful, fatal diseases often dont cause symptoms until after their victim has passed it on to their children.
Medical News Today (Free subscription) | 04/01/2008
The simple act of running in an exercise wheel delays the onset of some symptoms of Huntington's disease in a mouse model of the fatal human disorder according to research published in the open-access journal BMC Neuroscience. These findings add insights into the pathogenesis of the disease and suggest possible preventive therapeutic targets.
Medical News Today (Free subscription) | 03/31/2008
Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced that Sirtris Scientific Advisory Board Co-Chair Leonard P.
Medical News Today (Free subscription) | 03/24/2008
Research funded by the Wellcome Trust has provided a number of promising new drug targets for Huntington's disease, a neurodegenerative disease. Scientists at the University of Cambridge have identified a number of candidate drugs to investigate further which encourage cells to "eat" the malformed proteins that lead to the disease.
Medical News Today (Free subscription) | 03/13/2008
Medical News Today (Free subscription) | 02/05/2008
Hoping to piece together the intricate series of interactions that lead to Huntington's disease, Indiana University Bloomington scientists have determined the shape and structure of a binding site that may prove useful in combating the neurodegenerative disease.In the Feb.
Medical News Today (Free subscription) | 01/10/2008
The damaging effects of the mutated protein involved in Huntington's disease take place earlier in cell life than previously believed, said researchers from Baylor College of Medicine in Houston in a report that appears in the current edition of the journal Neuron.
Medical News Today (Free subscription) | 01/10/2008
Working with fruit flies, researchers have discovered a new mechanism by which the abnormal protein in Huntington's disease causes neurodegeneration. They have also manipulated the flies to successfully suppress that neurodegeneration, which they said suggests potential treatments to delay the onset and progression of the disease in humans.
Red Orbit (Free subscription) | 12/20/2007
NeuroSearch's ACR16 is set to become the market leader by 2010. Targeting a broad spectrum of symptoms, and possessing a novel mode of action, neurologists are likely to view this drug favorably when compared to current treatments. The launch of Xenazine (tetrabenazine) on the US market and further roll-out across the 5EU looks set to be a good strategic move by Prestwick Pharmaceuticals and Cambridge...
Business Wire (Free subscription) | 10/22/2007
CAMBRIDGE, Mass.--(BUSINESS WIRE)--CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that it has received the Marjorie Guthrie Leadership Award from the Huntington
